SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.62%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$652M
AUM Growth
+$652M
(+64%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
36.52%
Top 10 Holdings %
Top 10 Hldgs %
43.69%
Holding
147
New
54
Increased
27
Reduced
34
Closed
24
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$29.5M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
ISRL
Isramco Inc
ISRL
|
$22.1M |
| 4 |
Pfizer
PFE
|
$18.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$16.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$12.7M |
| 2 |
GSK
GSK
|
$9.33M |
| 3 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$8.94M |
| 4 |
Biogen
BIIB
|
$6.94M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.3M |
Sector Composition
| 1 | Healthcare | 70.86% |
| 2 | Technology | 5.53% |
| 3 | Energy | 3.84% |
| 4 | Industrials | 3.33% |
| 5 | Materials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
76
DELISTED
Immunomedics Inc
IMMU
| $1.99M | 0.25% |
534,050
-15,950
| -3% | -$59.3K |
|
77
Actinium Pharmaceuticals
ATNM
$53.3M
| $1.95M | 0.24% |
291,300
-8,700
| -3% | -$58.3K |
|
78
Snap-on
SNA
$16.8B
| $1.95M | 0.24% |
+16,100
| New | +$1.95M |
|
|
EIGR
79
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.94M | 0.24% |
185,656
+35,656
| +24% | +$376K |
|
|
KITE
80
DELISTED
Kite Pharma, Inc.
KITE
| $1.94M | 0.24% |
+67,970
| New | +$1.94M |
|
81
Mastercard
MA
$536B
| $1.92M | 0.24% |
+26,000
| New | +$1.92M |
|
|
BLUE
82
DELISTED
bluebird bio
BLUE
| $1.92M | 0.24% |
+53,405
| New | +$1.92M |
|
83
Larimar Therapeutics
LRMR
$337M
| $1.91M | 0.24% |
+97,100
| New | +$1.91M |
|
|
ALDR
84
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.9M | 0.24% |
+150,000
| New | +$1.9M |
|
|
MRNS
85
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.9M | 0.23% |
+293,533
| New | +$1.9M |
|
86
Ellomay Capital Ltd
ELLO
$229M
| $1.89M | 0.23% |
191,202
+170,638
| +830% | +$1.69M |
|
|
RNA
87
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $1.85M | 0.23% |
219,345
+94,345
| +75% | +$795K |
|
|
OMED
88
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.84M | 0.23% |
97,100
+22,100
| +29% | +$418K |
|
89
TJX Companies
TJX
$155B
| $1.63M | 0.2% |
27,600
+1,684
| +6% | +$99.6K |
|
|
RXDX
90
DELISTED
Ignyta, Inc.
RXDX
| $1.6M | 0.2% |
199,055
-5,945
| -3% | -$47.9K |
|
91
Talphera
TLPH
$11.2M
| $1.59M | 0.2% |
+289,849
| New | +$1.59M |
|
|
OCRX
92
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.57M | 0.19% |
321,254
+194,206
| +153% | +$952K |
|
|
RCPT
93
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.55M | 0.19% |
25,000
-35,000
| -58% | -$2.17M |
|
|
EPZM
94
DELISTED
Epizyme, Inc
EPZM
| $1.36M | 0.17% |
50,000
-63,188
| -56% | -$1.71M |
|
95
Cytokinetics
CYTK
$5.98B
| $1.28M | 0.16% |
363,212
+298,112
| +458% | +$1.05M |
|
|
GNVC
96
DELISTED
GenVec, Inc.
GNVC
| $1.16M | 0.14% |
558,325
-16,675
| -3% | -$34.7K |
|
|
CYTO
97
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $1.11M | 0.14% |
+191,300
| New | +$1.11M |
|
98
Enlivex Therapeutics
ENLV
$25.3M
| $1.09M | 0.13% |
+150,000
| New | +$1.09M |
|
|
PTN
99
DELISTED
Palatin Technologies
PTN
| $1.01M | 0.12% |
+1,084,466
| New | +$1.01M |
|
|
AFMD
100
DELISTED
Affimed
AFMD
| $945K | 0.12% |
+150,000
| New | +$945K |
|